Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma Journal Article


Authors: Palucka, A. K.; Dhodapkar, M. V.; Paczesny, S.; Burkeholder, S.; Wittkowski, K. M.; Steinman, R. M.; Fay, J.; Banchereau, J.
Article Title: Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma
Abstract: There is evidence that dendritic cell (DC) vaccines induce tumor-specific immune responses that correlate with clinical responses. Little is known, however, about the kinetics of T-cell responses to antigens presented on DC vaccines. The authors vaccinated 18 HLA A*0201+ patients with stage IV melanoma with CD34 HPC-derived DCs pulsed with six antigens: influenza matrix peptide (Flu-MP), KLH, and peptides derived from the four melanoma antigens: MART-1/Melan A, gp100, tyrosinase, and MAGE-3. A single DC vaccination was sufficient for induction of KLH-specific CD4 T-cell responses in five patients and Flu-MP-specific CD8 T-cell responses in eight patients. A single DC vaccine was sufficient for induction of tumor-specific effectors to at least one melanoma antigen in five patients. Thus, a single injection of CD34 HPC-derived DCs can lead to rapid immune response to CD4 epitopes or to melanoma antigens.
Keywords: adolescent; adult; clinical article; unclassified drug; neoplasm staging; cd8-positive t-lymphocytes; cd34 antigen; dendritic cell vaccine; cancer immunotherapy; melanoma; dendritic cell; tumor antigen; antigen presentation; lymphocyte activation; dendritic cells; cellular immunity; immune response; immunotherapy; antigens, neoplasm; cancer vaccine; cancer vaccines; cd4-positive t-lymphocytes; vaccination; cytotoxicity, immunologic; monophenol monooxygenase; cd4 antigen; antigens, cd34; immunotherapy, adoptive; vaccine; hla-a2 antigen; tumor immunology; cancer; humans; human; priority journal; article
Journal Title: Journal of Immunotherapy
Volume: 26
Issue: 5
ISSN: 1524-9557
Publisher: Lippincott Williams & Wilkins  
Date Published: 2003-09-01
Start Page: 432
End Page: 439
Language: English
DOI: 10.1097/00002371-200309000-00006
PUBMED: 12973032
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors